Edward Neuwelt M.D.
Edward Neuwelt, M.D., has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)
Edward Neuwelt M.D.
Edward Neuwelt, M.D., has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)
Ray Bergan, M.D.
Head, Division of Hematology and Medical Oncology, OHSU School of Medicine; Associate Director, Medical Oncology, OHSU Knight Cancer Institute. (OHSU)
Cancer motility
Raymond Bergan, M.D., (left) talks with Ryan Gordon, Ph.D., in the OHSU Bergan Basic Research Laboratory, May 23, 2018. A multidisciplinary team has discovered a drug compound that stops cancer cells from spreading throughout the body. (OHSU/Kristyna Wentz-Graff)
Cancer motility
(Left to right) Ryan Gordon, Ph.D., Raymond Bergan, M.D., Zhenzhen Zhang, Ph.D., M.P.H., Limin Zhang, Ph.D., Graham Fowler and Abhi Pattanayak in the OHSU Bergan Basic Research Laboratory, May 23, 2018. A multidisciplinary team has discovered a drug compound that stops cancer cells from spreading throughout the body. (OHSU/Kristyna Wentz-Graff)
Karl Scheidt, Ph.D.
Karl Scheidt, Ph.D., professor of chemistry and professor of pharmacology; director of the Center for Molecular Innovation and Drug Discovery; and executive director of the NewCures accelerator at Northwestern University. (Lemieux-Jordan/Northwestern University)
Ryan Gordon, Ph.D.
Ryan Gordon, Ph.D., research assistant professor in the OHSU School of Medicine and co-director of the Bergan lab. (OHSU/Kristyna Wentz-Graff)
UW research team
(Left to right) University of Washington researchers: Kevin Felt, Sung-gun Park, Juan Chavez, Jim Bruce, Jared Mohr, Xuefei Zhong, Martin Mathay, Andrew Keller. (Courtesy of the University of Washington)